For the Inventor, By the Inventor

Enter assignee name

Frankfurt-am-Main, Germany

Asta Pharma Aktiengesellschaft

USPTO Granted Patents = 29

Forward Citations = 387

Loading Chart...

Loading Chart...

54 inventors (with patents filed for the assignee):

Jurgen Engel (12 out of 81 patents)

Helmut Hettche (10 out of 25 patents)

Gerhard Scheffler (6 out of 18 patents)

4. Wolfgang Morick (4 out of 4 patents)

5. Ilona Fleischhauer (4 out of 9 patents)

6. Reinhard Muckenschnabel (4 out of 6 patents)

7. Dieter Sauerbier (4 out of 18 patents)

8. Istvan Szelenyi (3 out of 33 patents)

9. Bernd Nickel (3 out of 27 patents)

10. Wolfgang Schumacher (3 out of 9 patents)

11. Peter Hilgard (3 out of 17 patents)

12. Heinz Ulrich (3 out of 13 patents)

13. Carl-Heinrich Weischer (3 out of 5 patents)

14. Rainer Voegeli (3 out of 4 patents)

15. Peter Emig (2 out of 29 patents)

29 patents: Sort by Forward Citations

1. 6271254 - Pharmaceutical compositions containing R-&agr;-lipoic acid or S-&agr;-lipoic acid as active ingredient (2001-08-07),

2. 6017909 - Salts of azelastine having improved solubility effective at treating (2000-01-25),

3. 5998403 - Salts of azelastine having improved solubility useful at providing a (1999-12-07),

4. 5859003 - Salts of azelastine having improved solubility (1999-01-12),

5. 5728735 - Pharmaceutical composition containing R-.alpha.-lipoic acid or (1998-03-17),

6. 5334612 - Pharmaceutical compositions containing as active substance (1994-08-02),

7. 5290769 - Use of hexadecylphosphocholine for the treatment of psoriasis (1994-03-01),

8. 5271946 - Controlled release azelastine-containing pharmaceutical compositions (1993-12-21),

9. 5238955 - Ethylene-substituted phenylalkylethylenediamine-platinum (II or IV) (1993-08-24),

10. 5232919 - Azelastine embonate and compositions which contain it (1993-08-03),

11. 5204335 - Ifosfamide lyophilisate and process for its preparation (1993-04-20),

12. 5194644 - Ethylene-substituted phenylalkylethylene-diamine-platinum (II or IV) (1993-03-16),

13. 5164194 - Azelastine containing medicaments (1992-11-17),

14. 5110814 - Azelastine and its salts used to combat psoriasis (1992-05-05),

15. 5086050 - Method of treating inflammatory disorders and psoriasis with salts of (1992-02-04),

Asta Pharma Aktiengesellschaft is a pharmaceutical company specializing in the development and manufacturing of innovative medicines. With a focus on improving healthcare and quality of life, Asta Pharma aims to provide effective solutions for various medical conditions. Leveraging advanced research and development capabilities, the company strives to introduce cutting-edge therapies that meet the needs of patients worldwide.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 9 2025

29 Patents

#30 in Frankfurt-am-Main

#1,679 in Germany

#21,844 in the World

Frankfurt-am-Main, Germany

Asta Pharma Aktiengesellschaft

Forward Citations = 387

54 inventors:

Jurgen Engel (12 out of 81 patents)

Helmut Hettche (10 out of 25 patents)

Gerhard Scheffler (6 out of 18 patents)

4. Wolfgang Morick (4 out of 4 patents)

5. Ilona Fleischhauer (4 out of 9 patents)

Please report any incorrect information to support@idiyas.com

Loading…